skip to Main Content

Metabolome of pancreatic juice delineates distinct clinical Profiles of Pancreatic Cancer and Reveals a Link Between Glucose Metabolism and PD-1+ Cells

Newsfeed image, light gray text on dark gray background
Better understanding of pancreatic diseases, including pancreatic adenocarcinoma (PDAC), is an urgent medical need, with little advances in preoperative differential diagnosis, preventing rational selection of therapeutic strategies.

The clinical management of pancreatic cancer patients would benefit from the identification of variables distinctively associated to the multiplicity of pancreatic disorders. Read more . . .

 


Back To Top